Detalhe da pesquisa
1.
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC).
Future Oncol
; 19(3): 193-203, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974574
2.
Targeted therapies in advanced renal cell carcinoma: the role of metastatic sites as a prognostic factor.
Future Oncol
; 10(8): 1361-72, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25052747
3.
Palonosetron plus dexamethasone in highly emetogenic chemotherapy: pooled data from two Phase III trials.
Future Oncol
; 9(10): 1451-8, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24106896
4.
Beyond First-Line Immunotherapy: Potential Therapeutic Strategies Based on Different Pattern Progressions: Oligo and Systemic Progression.
Cancers (Basel)
; 13(6)2021 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803958
5.
Pimasertib Versus Dacarbazine in Patients With Unresectable NRAS-Mutated Cutaneous Melanoma: Phase II, Randomized, Controlled Trial with Crossover.
Cancers (Basel)
; 12(7)2020 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32610581
6.
Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis.
Cancer Res Treat
; 49(3): 834-845, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-27857020
7.
The tumor-targeting immunocytokine F16-IL2 in combination with doxorubicin: dose escalation in patients with advanced solid tumors and expansion into patients with metastatic breast cancer.
Cell Adh Migr
; 9(1-2): 14-21, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25562532